Entegrion, Incorporated Contract Details

Defense contract under the Army awarded to Entegrion, Incorporated on 9/22/2016.

Per the U.S. DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the U.S. DoD only publicly reports contracts valued at $6.5 million USD or greater.

The contract language is EXACTLY as it appears on the official U.S. DoD website (http://www.defense.gov/contracts/) unless otherwise noted.

Contractor: Entegrion, Incorporated
Department: Army
Awarded: 9/22/2016

Entegrion Inc.,* Durham, North Carolina, was awarded a $27,761,899 cost-plus-fixed-fee, incrementally funded contract with options for good clinical practices compliant, and good manufacturing practice Phase 2/3 clinical trial of a pooled, spray dried solvent detergent plasma product for treatment of patients with significant hemorrhaging. Bids were solicited via the Internet with one received. Work will be performed in Durham, North Carolina, with an estimated completion date of Sept. 27, 2019. Fiscal 2015 research, development, testing, and evaluation funds in the amount of $9,923,832 were obligated at the time of the award. Army Medical Research Acquisition Activity, Frederick, Maryland, is the contracting activity (W81XWH-16-C-0162).

Total Contract Value: $27,761,899

View all contracts that include "Entegrion, Incorporated" in the MiC database.